Literature DB >> 2012233

Role of baroreceptor afferents on area postrema-induced inhibition of sympathetic activity.

M Hay1, E M Hasser, K P Undesser, V S Bishop.   

Abstract

Activation of the area postrema by either electrical stimulation or chemical application of L-glutamate has been shown to result in an enhancement of cardiovascular baroreflexes similar to that seen with systemic infusions of arginine vasopressin (AVP). In addition, it has been found that the effects of AVP on baroreflex inhibition of renal sympathetic nerve activity (RSNA) are similar to those observed with phenylephrine following lesions of the area postrema or after partial denervation of baroreceptor afferents. The present study was undertaken to determine the role of baroreceptor afferent input on area postrema stimulation-induced decreases in sympathetic activity. In anesthetized rabbits, the responses of arterial pressure, heart rate, and RSNA to area postrema electrical stimulation were obtained before and after progressive sinoaortic denervation and vagotomy. Stimulation of the area postrema in carotid sinus-denervated animals consistently decreased RSNA in a frequency-dependent manner. However, following bilateral removal of both the aortic nerves and the vagi, electrical stimulation of the area postrema had no effect on RSNA. These results suggest that the ability of area postrema stimulation to inhibit RSNA is dependent on the presence of baroreceptor afferent input.

Entities:  

Mesh:

Year:  1991        PMID: 2012233     DOI: 10.1152/ajpheart.1991.260.4.H1353

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

Review 1.  Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure.

Authors:  I H Zucker; J L Liu
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

2.  Respiratory responses to electrical and chemical stimulation of the area postrema in the rabbit.

Authors:  M Srinivasan; F Bongianni; G A Fontana; T Pantaleo
Journal:  J Physiol       Date:  1993-04       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.